Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Christopher P Cannon Added: 6 years ago
This interview with Christopher P. Cannon from Brigham and Women's Hospital, Boston, US discusses Dual Antithrombotic Therapy with Dabigatran After Percutaneous Coronary Intervention in Patients with Atrial Fibrillation (REDUAL-PCI). Filmed by Radcliffe Cardiology on-site at ESC 2017. View more
Author(s): David Berg Added: 1 year ago
ESC Congress 22 — Dr David Berg (Brigham and Women's Hospital, US) shares key results from the TIMI Study Group's COVID-PACT trial (NCT04409834). This multicenter, randomized-controlled trial assessed efficacy and safety of full-dose vs. standard prophylactic dose anticoagulation and of antiplatelet vs. no antiplatelet therapy for prevention of venous and arterial thrombotic events. The study… View more
Author(s): George D Dangas Added: 2 years ago
In this short video, Dr George Dangas (Mount Sinai Hospital, New York, NY, US) shares the findings from the ENVISAGE-TAVI AF hot line trial presented at ESC Congress 2021. ENVISAGE-TAVI AF (Daiichi-Sankyo) compared the safety and efficacy of the DOAC edoxaban with VKAs (warfarin and its analogues) in atrial fibrillation patients with an indication for oral anticoagulation after successful TAVI. … View more
Author(s): Philip J Devereaux , John Eikelboom Added: 6 years ago
The effect of dabigatran in patients suffering myocardial injury after non-cardiac surgery - ACC 2018 An expert peer-to-peer discussion on the latest data to come out of the MANAGE trial and its implications for clinical practice. Sunday 11th March 2018 @ 11:45 EST ACC.18 Congress, Orlando, FL Discussants: Dr PJ Devereaux (Ontario, US) & Dr John Eikelboom (Ontario, US) Dr PJ… View more
Author(s): Otavio Berwanger , Prof José C Nicolau Added: 6 years ago
Explore the safety and efficacy of ticagrelor compared with clopidogrel in patients with acute coronary syndrome with ST elevation treated with thrombolysis - ACC 2018 An expert peer-to-peer discussion on the latest data to come out of the TREAT trial and its implications for clinical practice. Sunday 11th March 2018 @ 15:00 EST ACC.18 Congress, Orlando, FL Discussants: Dr Otavio Berwanger … View more
Author(s): Prof José C Nicolau , Christopher B Granger Added: 6 years ago
Explore the safety and efficacy of ticagrelor compared with clopidogrel in patients with acute coronary syndrome with ST elevation treated with thrombolysis - ACC 2018 An expert peer-to-peer discussion on the latest data to come out of the TREAT trial and its implications for clinical practice. Sunday 11th March 2018 @ 15:00 EST ACC.18 Congress, Orlando, FL Discussants: Dr Christopher Granger … View more
Research Area(s) / Expertise:

Atrial Arrhythmias

Atrial Fibrillation

Catheter Ablation of Cardiac Arrhythmias

Stroke

Prof Boyoung Joung is the Professor of Internal Medicine at theYonsei University in Seoul, South Korea. His research interests include atrial fibrillation, stroke, hypertension, and antithrombotic therapy. Prof Joung is a member of theArrhythmia & Electrophysiology Revieweditorial board. View more